{"database": "press", "table": "releases", "rows": [["https://comer.house.gov/2024/7/comer-announces-hearing-with-pbm-executives-on-role-in-rising-health-care-costs", "Comer Announces Hearing with PBM Executives on Role in Rising Health Care Costs", "2024-07-16", "2024", "2024-07", "Republican", "House", "KY", "James Comer", "C001108", "comer.house.gov", "comer", "https://comer.house.gov/media", "scraper", "WASHINGTON\u2014As part of an ongoing investigation into Pharmacy Benefit Managers\u2019 (PBMs) role in rising health care costs, House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) today announced an upcoming hearing titled, \u201cThe Role of Pharmacy Benefit Managers in Prescription Drug Markets Part III: Transparency and Accountability.\u201d At the hearing, members will examine how PBMs have used their position as middlemen to cement anticompetitive policies which have increased prescription drug costs, hurt independent pharmacies, and harmed patient care. Chief executives from three large PBMs, which collectively control 80 percent of the health market\u2014CVS Caremark, Express Scripts, and OptumRx\u2014are set to testify on their role in rising health care costs.\n\n.\n\n\u201cBoth Republicans and Democrats on the House Oversight Committee have sounded the alarm over anticompetitive tactics deployed by Pharmacy Benefit Managers and their role in rising drug prices. Information the Committee has obtained shows spread pricing and rebates benefit PBMs and have helped the three largest PBMs monopolize the pharmaceutical market. It\u2019s clear these self-benefitting practices only serve to help their bottom line rather than patients,\u201d said Chairman Comer. \u201cPBMs have been allowed to hide in the shadows for far too long. I look forward to the Oversight Committee continuing to work in a bipartisan fashion to shine a light on how these PBMs have undermined community pharmacies, raised prescriptions drug prices, and jeopardized patient care.\u201d\n\n.\n\nOn March 1, 2023, Chairman Comer launched an investigation into PBMs\u2019 role in rising health care costs. Information obtained by the Committee reveals PBMs have pushed deliberate, anticompetitive tactics, causing Americans to suffer from rising health care premiums and expensive prescription drug prices. Earlier this year, the Committee passed\u2014with broad bipartisan support\u2014the Delinking Revenue from Unfair Gouging (DRUG) Act which would reign in abusive practices by some PBMs that offer health plans under the Federal Employees Health Benefits program. State legislatures across the country have passed legislation preventing PBM anticompetitive practices and requiring transparency in pricing and contracts. The Federal Trade Commission also has an ongoing investigation into PBMs\u2019 anticompetitive actions. The Committee will continue to consider legislative solutions and work to ensure accountability for harmful PBM practices.\n\n.\n\nWHAT: Hearing titled, \u201cThe Role of Pharmacy Benefit Managers in Prescription Drug Markets Part III: Transparency and Accountability\u201d\n\n.\n\nDATE: Tuesday, July 23, 2024\n\n.\n\nTIME: 10:00 AM EST\n\n.\n\nLOCATION: 2154 Rayburn House Office Building\n\n.\n\nWITNESSES:\n\nAdam Kautzner, PharmD \u2013 President, Evernorth Care Management & Express Scripts\n\nDavid Joyner \u2013 Executive Vice President, CVS Health, and President CVS Caremark\n\nPatrick Conway, MD \u2013 Chief Executive Officer, OptumRx\n\n.\n\nWATCH: The hearing will be open to the public and press and will be livestreamed online at https://oversight.house.gov/\n\n.\n\nREAD MORE:\n\nHearing Wrap Up: Pharmacy Benefit Managers Prioritize Their Pocketbooks Over Patient Care", 1, "2026-03-30T01:40:41Z", "2026-04-07T21:24:45Z"]], "columns": ["url", "title", "date", "year", "month", "party", "chamber", "state", "member_name", "bioguide_id", "domain", "scraper", "source", "date_source", "text", "has_text", "collected_at", "updated_at"], "primary_keys": ["url"], "primary_key_values": ["https://comer.house.gov/2024/7/comer-announces-hearing-with-pbm-executives-on-role-in-rising-health-care-costs"], "units": {}, "query_ms": 0.7552069146186113, "source": "dwillis/congress-press", "source_url": "https://github.com/dwillis/congress-press", "license": "MIT", "license_url": "https://github.com/dwillis/congress-press/blob/main/LICENSE"}